StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
CareRx Corporation
Toronto Stock Exchange:CRRX.TO
Sector
Location
Market Cap
USD 133.93 M
Share Price
USD 2.13
Avg Daily Volume
43,588
Change (1 day)
-0.09%
Change (1 year)
25.34%
Change (YTD)
48.77%
CareRx Corporation Research and Development (R&D) Expenses for the year ending December 31, 2024: USD 0.00
CareRx Corporation Research and Development (R&D) Expenses is USD 0.00 for the year ending December 31, 2024. Research and development (R&D) expenses are the costs associated with the development of new products, technologies, or improvements to existing products.
-
CareRx Corporation Research and Development (R&D) Expenses for the year ending December 31, 2023 was USD 0.00.
-
CareRx Corporation Research and Development (R&D) Expenses for the year ending December 31, 2022 was USD 0.00.
-
CareRx Corporation Research and Development (R&D) Expenses for the year ending December 31, 2021 was USD 0.00.
-
CareRx Corporation Research and Development (R&D) Expenses for the year ending December 31, 2020 was USD 0.00.
Competitors
Chemed Corporation
USD 470.72
CHE
+7.70
1.66%
UnitedHealth Group Incorporated
USD 281.06
UNH
+2.48
0.89%
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
McKesson Corporation
USD 711.82
MCK
+1.63
0.23%
CVS Health Corporation
USD 60.70
CVS
+1.95
3.32%
Elevance Health Inc.
USD 289.10
ELV
+8.67
3.09%
Cencora, Inc.
USD 290.36
COR
-0.09
-0.03%
Cardinal Health, Inc.
USD 157.14
CAH
-1.14
-0.72%
BeOne Medicines Ltd.
USD 291.47
ONC
-4.99
-1.68%
Humana Inc.
USD 237.98
HUM
+8.77
3.83%
JD Health International Inc.
USD 6.13
6618.HK
-0.03
-0.52%
Fresenius Medical Care AG & Co. KGaA
USD 52.85
FME.DE
-0.95
-1.76%
Encompass Health Corporation
USD 107.67
EHC
+0.54
0.50%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
USD 2.40
2196.HK
+0.04
1.73%
Demant A/S
USD 43.90
DEMANT.CO
+0.10
0.23%
Shanghai Pharmaceuticals Holding Co., Ltd
USD 1.62
2607.HK
-0.01
-0.47%
The Ensign Group, Inc.
USD 150.06
ENSG
+12.29
8.92%
Sinopharm Group Co. Ltd.
USD 2.46
1099.HK
-0.01
-0.21%
Stevanato Group S.p.A.
USD 26.51
STVN
-1.44
-5.15%
Haisco Pharmaceutical Group Co., Ltd.
USD 6.72
002653.SZ
+0.01
0.22%
Key Data
| Date | Research and Development (R&D) Expenses | Revenue | Revenue | Gross Profit |
|---|
Competitors
Chemed Corporation
USD 470.72
CHE
+7.70
1.66%
UnitedHealth Group Incorporated
USD 281.06
UNH
+2.48
0.89%
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
McKesson Corporation
USD 711.82
MCK
+1.63
0.23%
CVS Health Corporation
USD 60.70
CVS
+1.95
3.32%
Elevance Health Inc.
USD 289.10
ELV
+8.67
3.09%
Cencora, Inc.
USD 290.36
COR
-0.09
-0.03%
Cardinal Health, Inc.
USD 157.14
CAH
-1.14
-0.72%
BeOne Medicines Ltd.
USD 291.47
ONC
-4.99
-1.68%
Humana Inc.
USD 237.98
HUM
+8.77
3.83%
JD Health International Inc.
USD 6.13
6618.HK
-0.03
-0.52%
Fresenius Medical Care AG & Co. KGaA
USD 52.85
FME.DE
-0.95
-1.76%
Encompass Health Corporation
USD 107.67
EHC
+0.54
0.50%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
USD 2.40
2196.HK
+0.04
1.73%
Demant A/S
USD 43.90
DEMANT.CO
+0.10
0.23%
Shanghai Pharmaceuticals Holding Co., Ltd
USD 1.62
2607.HK
-0.01
-0.47%
The Ensign Group, Inc.
USD 150.06
ENSG
+12.29
8.92%
Sinopharm Group Co. Ltd.
USD 2.46
1099.HK
-0.01
-0.21%
Stevanato Group S.p.A.
USD 26.51
STVN
-1.44
-5.15%
Haisco Pharmaceutical Group Co., Ltd.
USD 6.72
002653.SZ
+0.01
0.22%